AER Label Guidance Holds To Requiring Full Addresses For OTCs, Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA is extending the deadline for serious adverse event labeling requirements for OTC drugs and dietary supplements until January 2010 because it has yet to finalize its guidance to comply with those regulations